financetom
Business
financetom
/
Business
/
10,860 cases under IBC pending before NCLT at the end of September: Government tells Rajya Sabha
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
10,860 cases under IBC pending before NCLT at the end of September: Government tells Rajya Sabha
Dec 3, 2019 12:05 PM

More than 10,800 cases are pending under the Insolvency and Bankruptcy Code before the National Company Law Tribunal at the end of September 2019, the Rajya Sabha was informed on Tuesday.

"As per the data provided by National Company Law Tribunal (NCLT), total 19,771 cases were pending with NCLT benches on 30.09.2019, which include 10,860 cases under Insolvency and Bankruptcy Code (IBC), 2016," minister of state for finance and corporate affairs Anurag Singh Thakur said in a written reply.

In a separate reply, the minister said that out of 18,782 cases filed under IBC, 2016 at the end of June 2019, 2,173 cases were admitted under the Code.

"Out of 2,173 admitted cases, 1,274 cases were ongoing under different stages of the resolution process, 129 cases have resulted in resolution, 491 cases have been approved for the commencement of liquidation process, 279 cases have been closed," he said.

The action is taken as per the provisions of the Code in all these cases admitted under the Code, Thakur added.

(With inputs from PTI)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Baxter International's Clinolipid Injection Approved for Expanded Use in US
Baxter International's Clinolipid Injection Approved for Expanded Use in US
May 13, 2024
09:28 AM EDT, 05/13/2024 (MT Newswires) -- Baxter International ( BAX ) said early Monday it has received expanded regulatory approval in the US for its Clinolipid injectable mixed-oil lipids emulsion for use in pediatric patients of all ages, including in preterm and newborn infants. Clinolipid has been approved by the US Food and Drug Administration since 2019 to provide...
EV startup Fisker to raise funds, pause production after missing interest payment (March 18)
EV startup Fisker to raise funds, pause production after missing interest payment (March 18)
May 13, 2024
March 18 (Reuters) - Fisker ( FSRN ) said on Monday it would pause production of its electric vehicles for six weeks and raise up to $150 million in funding by selling convertible notes after missing an interest payment, as the startup tries to navigate a cash crunch. The company added that none of its Ocean SUVs were produced in...
Ascendis Says Late-Stage Trial Shows 'Significant' Improvements in Kidney Function for Adults Treated With TransCon PTH
Ascendis Says Late-Stage Trial Shows 'Significant' Improvements in Kidney Function for Adults Treated With TransCon PTH
May 13, 2024
09:29 AM EDT, 05/13/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday that two-year data from an analysis of a late-stage trial showed significant and sustained improvements in renal function in people with chronic hypoparathyroidism treated with TransCon PTH. The results were presented during this year's European Congress of Endocrinology, the company said. Ascendis said the late-stage study...
BRIEF-Arthur J. Gallagher & Co Acquires Acumen Advisors
BRIEF-Arthur J. Gallagher & Co Acquires Acumen Advisors
May 13, 2024
May 13 (Reuters) - Arthur J Gallagher & Co ( AJG ): * ARTHUR J. GALLAGHER & CO. ( AJG ) ACQUIRES ACUMEN ADVISORS, INC. * ARTHUR J GALLAGHER & CO ( AJG ): TERMS OF TRANSACTION WERE NOT DISCLOSED Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved